Latest Manufacturing News

Industrial Minerals Ltd has announced a maiden inferred mineral resource estimate of 6.2 million tonnes at 98% silica for its Pippingarra Quarry Project, alongside successful testwork and a 12-month option extension.

Ragusa Minerals has signed a binding agreement to acquire a 60% controlling interest in Pegasus Tel Inc., gaining access to the Purple Pansy Manganese-Gold Project in Arizona, a critical mineral asset aligned with US government priorities.

MinRex Resources reports promising rare earth element and titanium dioxide results from its maiden drilling at the Fraser Range Project, while extending its option to acquire a 50% stake until January 2026.

Lithium Energy Limited is progressing exploration and development across multiple battery mineral projects following the sale of its flagship Solaroz Lithium Project, while working to meet ASX reinstatement conditions.

Morella Corporation’s September quarter report reveals significant progress in its diversified critical minerals portfolio, including new titanium-vanadium exposure and streamlined US lithium assets. The company is gearing up for drilling and resource definition in 2026, supported by strengthened funding.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Ark Mines secured a $4.5 million strategic investment from QIC to fast-track its Sandy Mitchell Rare Earth Project, achieving key drilling and environmental milestones that pave the way for production by late 2027.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

1414 Degrees has completed key milestones on its SiBox technology, advanced SiBrick storage media towards mass production, and acquired an exclusive licence for innovative silicon nanoparticle tech, backed by a $1.214 million capital raise.

Zimi Limited reported a remarkable 367% increase in quarterly revenue alongside a successful $1.85 million capital raise and completion of its manufacturing relocation, setting the stage for accelerated growth in the smart home IoT sector.